See the DrugPatentWatch profile for Impoyz
What is Impoyz?
Impoyz is a prescription medicine for plaque psoriasis. It contains deucravacitinib, a targeted medicine that works by blocking a specific immune pathway involved in psoriasis (TYK2 signaling) [1].
How does Impoyz work?
Deucravacitinib (in Impoyz) inhibits TYK2, a key enzyme in the signaling pathway used by several inflammatory cytokines. By dampening that signaling, it helps reduce psoriasis inflammation and plaques [1].
How is Impoyz taken?
The provided information does not include dosing or administration details. [1]
What should patients ask about before using Impoyz?
Patients often ask clinicians about expected response time, what to do if symptoms worsen, and safety monitoring requirements for targeted immune-modulating drugs. The provided information here does not list these specifics. [1]
What side effects are commonly associated with Impoyz?
The provided information does not list specific side effects. [1]
Is Impoyz available by prescription only?
Yes. Impoyz is a prescription medicine. [1]
Where can I find official information?
For the most accurate, up-to-date details (including prescribing information), check the manufacturer or regulator-linked product page for Impoyz [1].
Sources:
[1] https://www.imanifest.com/brand/impoyz/